Vivani Medical Stock Performance

VANI Stock  USD 1.18  0.01  0.85%   
The entity has a beta of 0.79, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Vivani Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vivani Medical is expected to be smaller as well. At this point, Vivani Medical has a negative expected return of -0.25%. Please make sure to validate Vivani Medical's potential upside, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Vivani Medical performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Vivani Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Last Split Factor
1:3
Dividend Date
2020-01-06
Last Split Date
2022-08-19
1
Acquisition by Dwyer Donald of 1000 shares of Vivani Medical at 1.13 subject to Rule 16b-3
11/19/2025
2
Vivani Medical Upgraded at Wall Street Zen
11/25/2025
3
Acquisition by Williams Gregg of 1473214 shares of Vivani Medical at 1.12 subject to Rule 16b-3
12/15/2025
4
Acquisition by Mendelsohn Aaron of 20000 shares of Vivani Medical at 1.23 subject to Rule 16b-3
12/29/2025
5
Vivani medical director Mendelsohn buys 24,600 in VANI stock By Investing.com - Investing.com Australia
12/31/2025
6
Contrasting Vivani Medical Zoetis
01/08/2026
7
Vivani Subsidiary Cortigent to Present Orion Systems Advanced Brain Implant Technology in Poster Session at NANS 2026
01/22/2026
8
Insider Buying Vivani Medical Director Purchases 1,981,052.10 in Stock
01/23/2026
9
Vivani Medical Prices 4.5M Offering for Growth Initiatives - Intellectia AI
01/26/2026
10
Vivani Medical Director Acquires 1,351,351 Shares - MarketBeat
01/28/2026
11
Why your eyes water more in the cold and how to stop it
02/05/2026
12
GLP-1s may help preserve your vision as you age with an important health-related caveat
02/12/2026
Begin Period Cash Flow22 M
Total Cashflows From Investing Activities-556 K

Vivani Medical Relative Risk vs. Return Landscape

If you would invest  147.00  in Vivani Medical on November 15, 2025 and sell it today you would lose (26.00) from holding Vivani Medical or give up 17.69% of portfolio value over 90 days. Vivani Medical is currently does not generate positive expected returns and assumes 3.7905% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Vivani, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Vivani Medical is expected to under-perform the market. In addition to that, the company is 4.92 times more volatile than its market benchmark. It trades about -0.07 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of volatility.

Vivani Medical Target Price Odds to finish over Current Price

The tendency of Vivani Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.18 90 days 1.18 
about 98.0
Based on a normal probability distribution, the odds of Vivani Medical to move above the current price in 90 days from now is about 98.0 (This Vivani Medical probability density function shows the probability of Vivani Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Vivani Medical has a beta of 0.79. This entails as returns on the market go up, Vivani Medical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Vivani Medical will be expected to be much smaller as well. Additionally Vivani Medical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Vivani Medical Price Density   
       Price  

Predictive Modules for Vivani Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vivani Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.061.194.98
Details
Intrinsic
Valuation
LowRealHigh
0.112.145.93
Details
2 Analysts
Consensus
LowTargetHigh
4.555.005.55
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.09-0.09-0.09
Details

Vivani Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Vivani Medical is not an exception. The market had few large corrections towards the Vivani Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vivani Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vivani Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.38
β
Beta against Dow Jones0.79
σ
Overall volatility
0.09
Ir
Information ratio -0.1

Vivani Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vivani Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vivani Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Vivani Medical generated a negative expected return over the last 90 days
Vivani Medical may become a speculative penny stock
Vivani Medical has high historical volatility and very poor performance
Vivani Medical has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (23.49 M) with profit before overhead, payroll, taxes, and interest of 130 K.
Vivani Medical currently holds about 3.45 M in cash with (20.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Vivani Medical has a poor financial position based on the latest SEC disclosures
Roughly 36.0% of the company outstanding shares are owned by insiders
Latest headline from nypost.com: GLP-1s may help preserve your vision as you age with an important health-related caveat

Vivani Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vivani Stock often depends not only on the future outlook of the current and potential Vivani Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vivani Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding55 M
Cash And Short Term Investments18.4 M

Vivani Medical Fundamentals Growth

Vivani Stock prices reflect investors' perceptions of the future prospects and financial health of Vivani Medical, and Vivani Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vivani Stock performance.

About Vivani Medical Performance

By evaluating Vivani Medical's fundamental ratios, stakeholders can gain valuable insights into Vivani Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Vivani Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Vivani Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 200.71  310.98 
Return On Tangible Assets(0.51)(0.53)
Return On Capital Employed(0.62)(0.66)
Return On Assets(0.51)(0.53)
Return On Equity(1.53)(1.61)

Things to note about Vivani Medical performance evaluation

Checking the ongoing alerts about Vivani Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vivani Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Vivani Medical generated a negative expected return over the last 90 days
Vivani Medical may become a speculative penny stock
Vivani Medical has high historical volatility and very poor performance
Vivani Medical has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (23.49 M) with profit before overhead, payroll, taxes, and interest of 130 K.
Vivani Medical currently holds about 3.45 M in cash with (20.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Vivani Medical has a poor financial position based on the latest SEC disclosures
Roughly 36.0% of the company outstanding shares are owned by insiders
Latest headline from nypost.com: GLP-1s may help preserve your vision as you age with an important health-related caveat
Evaluating Vivani Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Vivani Medical's stock performance include:
  • Analyzing Vivani Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vivani Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Vivani Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Vivani Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vivani Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Vivani Medical's stock. These opinions can provide insight into Vivani Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Vivani Medical's stock performance is not an exact science, and many factors can impact Vivani Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Vivani Stock analysis

When running Vivani Medical's price analysis, check to measure Vivani Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivani Medical is operating at the current time. Most of Vivani Medical's value examination focuses on studying past and present price action to predict the probability of Vivani Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivani Medical's price. Additionally, you may evaluate how the addition of Vivani Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance